Robert John
Fortune : 50 351 $ au 30/06/2026
Fortune : 50 351 $ au 30/06/2026
Robert John is currently Chief Revenue Officer at CVRx, Inc. since 2024.
Formerly, Mr. John was General Manager-Cardiac Rhythm Management EMEA at Abbott Laboratories from 2008 to 2023.
Education includes graduate studies at The University of Alabama and undergraduate studies at the University of North Texas.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CVRX, INC. 0,04% | 06/04/2026 | 9 796 ( 0,04% ) | 50 351 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CVRX, INC. | Corporate Officer/Principal | 27/06/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2023 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
The University of Alabama
The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of North Texas
University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CVRx, Inc.
CVRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes neuromodulation device & implantable technology to treat hypertension and heart failure | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national